| Trial ID: | L3737 |
| Source ID: | NCT03700801
|
| Associated Drug: |
Triple Combination Therapy Group
|
| Title: |
Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Triple combination therapy group|DRUG: Premixed insulin therapy group
|
| Outcome Measures: |
Primary: HbA1c, Changes in HbA1c after 12 weeks of intervention., 12 weeks | Secondary: fasting/2-hour postprandial blood glucose, Changes in fasting/2-hour postprandial blood glucose after 12 weeks of intervention., 12 weeks|Fasting/2-hour postprandial c-peptide, Changes in fasting/2-hour postprandial c-peptide after 12 weeks of intervention., 12 weeks|Weight, Change in weight after 12 weeks of intervention., 12 weeks|Rate of hypoglycemia, Rate of hypoglycemia in two groups., 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Zhujiang Hospital | Collaborators: The Sixth Affiliated Hospital of Guangzhou Medical University|Third Affiliated Hospital, Sun Yat-Sen University|Peking University Shenzhen Hospital|Dongguan Kanghua Hospital|First People's Hospital, Shunde China|The First Affiliated Hospital of Guangdong Pharmaceutical University|The Fifth Affiliated Hospital of Zunyi Medical College|Shenzhen Sixth People's Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
130
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2018-10-01
|
| Completion Date: |
2019-12-20
|
| Results First Posted: |
|
| Last Update Posted: |
2024-03-18
|
| Locations: |
The Pearl River Hospital of Southern Medical University, Guangzhou, Guangdong, 510300, China
|
| URL: |
https://clinicaltrials.gov/show/NCT03700801
|
